Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06521411 · ClinicalTrials.gov registry record · NA

Pilot Subsidized and Culturally-adapted Community Supported Agriculture (CSA) Program

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT06521411: Completed NA study, sponsored by NYU Langone Health.

NCT06521411 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06521411, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

This study aims to apply community-engaged methods to refine and implement a culturally adapted systems-level program for improving diet in low income, Chinese American immigrants. Guided by the regular partner engagement, The researchers have organically developed a systems-level program to bring a subsidized community-supported agriculture (CSA) model to the community in a way that is aligned with cultural values, and that includes culturally appropriate produce and nutrition education. This is a single-site proof of concept pilot program that will be evaluated using a pre-post-design.

Primary Outcome

Diet quality will be self-reported via a follow-up survey. The participant is presented with a list of 29 different vegetables - he/she is asked to select all of the vegetables in the list that was consumed in the past month.

Interventions

  • BEHAVIORAL CSA model

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2022-05-24
Est. Completion 2022-11-01
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT06521411 record still lists

NCT06521411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which CSA model is the first listed.

NCT06521411 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06521411 about?

NCT06521411 is a clinical study titled "Pilot Subsidized and Culturally-adapted Community Supported Agriculture (CSA) Program". This study aims to apply community-engaged methods to refine and implement a culturally adapted systems-level program for improving diet in low income, Chinese American immigrants. Guided by the regular partner engagement, The researchers have organically developed a systems-level program to bring a...

What is the current status of trial NCT06521411?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-05-24. Estimated completion is 2022-11-01.

What interventions are being tested in trial NCT06521411?

The interventions under investigation include: CSA model (BEHAVIORAL).

Who is sponsoring clinical trial NCT06521411?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06521411's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06521411, the US trial registry maintained by the National Library of Medicine. NCT06521411 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.